"10.1371_journal.pone.0092647","plos one","2014-03-25T00:00:00Z","Mayu Watanabe; Atsuko Nakatsuka; Kazutoshi Murakami; Kentaro Inoue; Takahiro Terami; Chigusa Higuchi; Akihiro Katayama; Sanae Teshigawara; Jun Eguchi; Daisuke Ogawa; Eijiro Watanabe; Jun Wada; Hirofumi Makino","Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Kita-ku, Okayama, Japan; Department of Diabetic Nephropathy, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Kita-ku, Okayama, Japan; Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Kita-ku, Okayama, Japan; Dainippon Sumitomo Pharma, Chuo-Ku, Osaka, Japan","Conceived and designed the experiments: MW AN EW JW HM. Performed the experiments: MW AN KM KI TT CH AK ST JE DO JW. Analyzed the data: MW AN JW HM. Contributed reagents/materials/analysis tools: EW. Wrote the paper: MW AN JW HM.","DO and AN belong to the Department of Diabetic Nephropathy endowed by Astellas and Boehringer Ingelheim. JW is a consultant for Boehringer Ingelheim, receives speaker honoraria from Novartis. HM is a consultant for AbbVie, Astellas and Teijin, receives speaker honoraria from Astellas, MSD, Takeda, and Tanabe Mitsubishi, and receives grant support from Astellas, Daiichi Sankyo, Dainippon Sumitomo, MSD, Novo Nordisk, Takeda and Kyowa Hakko Kirin. E. Watanabe is an emplyee of Dainippon Sumitomo Pharma. This does not alter the authorss adherence to all the PLOS ONE policies on sharing data and materials.","2014","03","Mayu Watanabe","MW",13,TRUE,5,11,4,4,TRUE,TRUE,FALSE,0,NA,FALSE
